These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Information from your family doctor. Hidradenitis suppurativa: what you should know. American Academy of Family Physicians Am Fam Physician; 2005 Oct; 72(8):1554. PubMed ID: 16273822 [No Abstract] [Full Text] [Related]
27. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J; J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366 [TBL] [Abstract][Full Text] [Related]
28. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group. Horváth B; Janse IC; Blok JL; Driessen RJ; Boer J; Mekkes JR; Prens EP; van der Zee HH Acta Derm Venereol; 2017 Mar; 97(3):412-413. PubMed ID: 27535129 [No Abstract] [Full Text] [Related]
29. Hidradenitis suppurativa: a painful and debilitating condition. Spear M Plast Surg Nurs; 2010; 30(4):256-8. PubMed ID: 21217374 [No Abstract] [Full Text] [Related]
30. Prepubertal onset of hidradenitis suppurativa in a girl: A case report and literature review. Stojkovic-Filipovic JM; Gajic-Veljic MD; Nikolic M Indian J Dermatol Venereol Leprol; 2015; 81(3):294-8. PubMed ID: 25784224 [No Abstract] [Full Text] [Related]
31. Moving toward structured, specialized hidradenitis suppurativa care to improve patient outcomes. Kearney N; Kirby B Br J Dermatol; 2023 Aug; 189(3):e57-e58. PubMed ID: 37317955 [No Abstract] [Full Text] [Related]
33. [Diagnosis and treatment of acne inversa]. Gronau E; Pannek J Dtsch Med Wochenschr; 2002 Aug; 127(34-35):1761-3. PubMed ID: 12192635 [No Abstract] [Full Text] [Related]
34. Hidradenitis suppurativa: a disease of apocrine gland physiology. Lasko LA; Post C; Kathju S JAAPA; 2008 Nov; 21(11):23-5. PubMed ID: 19105543 [No Abstract] [Full Text] [Related]
35. The Hidradenitis Suppurativa (HS) "Multidisciplinary Unit": a rationale and practical proposal for an organised clinical approach. Chiricozzi A; Veraldi S; Fabbrocini G; Didona B; Pasquinucci S; Micali G; Romanelli M Eur J Dermatol; 2018 Apr; 28(2):274-275. PubMed ID: 29619988 [No Abstract] [Full Text] [Related]
36. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab. Harde V; Mrowietz U J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236 [TBL] [Abstract][Full Text] [Related]
37. The Handicap of Hidradenitis Suppurativa. Deckers IE; Kimball AB Dermatol Clin; 2016 Jan; 34(1):17-22. PubMed ID: 26617353 [TBL] [Abstract][Full Text] [Related]
38. Hidradenitis suppurativa through the lens of YouTube: A cross-sectional analysis. Li W; Ma JE; Chan AA; Lee DJ; Smogorzewski J J Am Acad Dermatol; 2021 May; 84(5):1398-1399. PubMed ID: 32522514 [No Abstract] [Full Text] [Related]
39. The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. Bettoli V; Pasquinucci S; Caracciolo S; Piccolo D; Cazzaniga S; Fantini F; Binello L; Pintori G; Naldi L J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1965-1970. PubMed ID: 27136185 [TBL] [Abstract][Full Text] [Related]
40. Infliximab for the treatment of hidradenitis suppurativa. Fernández-Vozmediano JM; Armario-Hita JC Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]